Nonalcoholic Fatty Liver Disease and Associated Metabolic Risks of Hypertension in Type 2 Diabetes: A Cross-Sectional Community-Based Study

International Journal of Endocrinology

Volumn 2017, Issue , 2017, Pages

  Ding, Xiaoying ^a,b   Xu, Ying ^c   Wang, Yufan ^a   Li, Xiaohua ^a   Lu, Chunhua ^d   Su, Jing ^a   Ma, Yuhang ^a   Chen, Yuting ^a   Yin, Yanhua ^a   Zhang, Lijun ^a   Wu, Yong ^c   Jin, Yaqiong ^c   Zheng, Lijun ^c   Xu, Songmei ^c   Zhu, Xiuli ^c   Ma, Jilin ^d   Yu, Lihua ^d   Jiang, Junyi ^e   Zhao, Naisi ^f   Yan, Qingwu ^b   Greenberg, Andrew S ^b   Huang, Qianfang ^a   Ren, Qian ^a   Sun, Haiyan ^a   Gu, Mingyu ^a   Zhao, Li ^a   Huang, Yunhong ^a   Wu, Yijie ^a   Qian, Chunxian ^c   Peng, Yongde ^a   more..

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TUFTS UNIVERSITY   (United States)

^c Si Jing Hospital   (China)

^d Fangsong Community Health Service Center of Songjiang District   (China)

^e Pudong New Area Center for Disease Control and Prevention   (China)

^f TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIOTHYRONINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL; URIC ACID;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOMETABOLIC RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPERURICEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; POSTPRANDIAL STATE; PREVALENCE; RISK ASSESSMENT; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 85018630008     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2017/5262560     Document Type: Article

References (40)

1. L. Guariguata, D. R. Whiting, I. Hambleton, J. Beagley, U. Linnenkamp, and J. E. Shaw, "Global estimates of diabetes prevalence for 2013 and projections for 2035," Diabetes Research and Clinical Practice, vol. 103, no. 2, pp. 137-149, 2014.
2. S. Horr and S. Nissen, "Managing hypertension in type 2 diabetes mellitus," Best Practice & Research: Clinical Endocrinology & Metabolism, vol. 30, no. 3, pp. 445-454, 2016.
3. X. Ding, X. Zheng, A. Xing et al., "High risk factors of atrial fibrillation in type 2 diabetes: results from the Chinese Kailuan study," QJM: Monthly Journal of the Association of Physicians, vol. 108, no. 11, pp. 885-890, 2015.
4. N. Perera, J. Indrakumar, W. V. Abeysinghe, V. Fernando, W. M. Samaraweera, and J. S. Lawrence, "Non alcoholic fatty liver disease increases the mortality from acute coronary syndrome: an observational study from Sri Lanka," BMC Cardiovascular Disorders, vol. 16, no. 1, p. 37, 2016.
5. A. Mantovani, M. Pernigo, C. Bergamini et al., "Nonalcoholic fatty liver disease is independently associated with early left ventricular diastolic dysfunction in patients with type 2 diabetes," PloS One, vol. 10, no. 8, Article ID e0135329, 2015.
6. L. Lukic, N. M. Lalic, N. Rajkovic et al., "Hypertension in obese type 2 diabetes patients is associated with increases in insulin resistance and IL-6 cytokine levels: potential targets for an efficient preventive intervention," International Journal of Environmental Research and Public Health, vol. 11, no. 4, pp. 3586-3598, 2014.
7. H. Smulyan, A. Lieber, and M. E. Safar, "Hypertension, diabetes type II, and their association: role of arterial stiffness," American Journal of Hypertension, vol. 29, no. 1, pp. 5-13, 2016.
8. A. Majumdar, P. Misra, S. Sharma, S. Kant, A. Krishnan, and C. S. Pandav, "Prevalence of nonalcoholic fatty liver disease in an adult population in a rural community of Haryana, India," Indian Journal of Public Health, vol. 60, no. 1, pp. 26-33, 2016.
9. S. Wang, C. Zhang, G. Zhang et al., "Association between white blood cell count and non-alcoholic fatty liver disease in urban Han Chinese: a prospective cohort study," BMJ Open, vol. 6, no. 6, Article ID e010342, 2016.
10. S. Lallukka and H. Yki-Jarvinen, "Non-alcoholic fatty liver disease and risk of type 2 diabetes," Best Practice & Research: Clinical Endocrinology & Metabolism, vol. 30, no. 3, pp. 385-395, 2016.
11. H. Yamazaki, T. Tsuboya, K. Tsuji, M. Dohke, and H. Maguchi, "Independent association between improvement of nonalcoholic fatty liver disease and reduced incidence of type 2 diabetes," Diabetes Care, vol. 38, no. 9, pp. 1673-1679, 2015.
12. D. Zou, Y. Ye, N. Zou, and J. Yu, "Analysis of risk factors and their interactions in type 2 diabetes mellitus: a crosssectional survey in Guilin, China," Journal of Diabetes Investigation, 2016.
13. I. Mikolasevic, S. Milic, S. Racki et al., "Nonalcoholic fatty liver disease (NAFLD)-a new cardiovascular risk factor in peritoneal dialysis patients," Peritoneal Dialysis International, vol. 36, no. 4, pp. 427-432, 2016.
14. L. H. Yan, B. Mu, Y. Guan et al., "Assessment of the relationship between non-alcoholic fatty liver disease and diabetic complications," Journal of Diabetes Investigation, vol. 7, no. 6, pp. 889-894, 2016.
15. T. Kogiso, "Clinical importance of non-alcoholic fatty liver diseases. Topics: IV. Relation of NAFLD with lifestylerelated disease including obesity, dyslipidemia and hypertension," Nihon Naika Gakkai Zasshi, vol. 105, no. 1, pp. 31-37, 2016.
16. American Diabetes Association, "Diagnosis and classification of diabetes mellitus," Diabetes Care, vol. 33, Supplement 1, pp. S62-S69, 2010.
17. A. V. Chobanian, G. L. Bakris, H. R. Black et al., "Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure," Hypertension, vol. 42, no. 6, pp. 1206-1252, 2003.
18. World Health Organization, "Obesity: preventing and managing the global epidemic. Report of a WHO consultation," World Health Organization Technical Report Series, vol. 894, no. i-xii, pp. 1-253, 2000.
19. Y. Bao, J. Lu, C. Wang et al., "Optimal waist circumference cutoffs for abdominal obesity in Chinese," Atherosclerosis, vol. 201, no. 2, pp. 378-384, 2008.
20. W. Jia, "Status of insulin resistance in Chinese population," International Journal of Endocrinology and Metabolism, vol. 22, no. 4, p. 264, 2002.
21. D. I. Feig, D. H. Kang, and R. J. Johnson, "Uric acid and cardiovascular risk," The New England Journal of Medicine, vol. 359, no. 17, pp. 1811-1821, 2008.
22. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, "Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)," JAMA, vol. 285, no. 19, pp. 2486-2497, 2001.
23. M. D. Zeng, J. G. Fan, L. G. Lu et al., "Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases," Journal of Digestive Diseases, vol. 9, no. 2, pp. 108-112, 2008.
24. W. Deng, Y. Zhang, Y. Zheng et al., "Serum retinol-binding protein 4 levels are elevated but do not contribute to insulin resistance in newly diagnosed Chinese hypertensive patients," Diabetology and Metabolic Syndrome, vol. 6, no. 1, p. 72, 2014.
25. E. Bugianesi, A. Gastaldelli, E. Vanni et al., "Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms," Diabetologia, vol. 48, no. 4, pp. 634-642, 2005.
26. S. R. Thorn, K. C. Baquero, S. A. Newsom et al., "Early life exposure to maternal insulin resistance has persistent effects on hepatic NAFLD in juvenile nonhuman primates," Diabetes, vol. 63, no. 8, pp. 2702-2713, 2014.
27. M. Gaggini, M. Morelli, E. Buzzigoli, D. F. RA, E. Bugianesi, and A. Gastaldelli, "Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease," Nutrients, vol. 5, no. 5, pp. 1544-1560, 2013.
28. E. Bonci, C. Chiesa, P. Versacci, C. Anania, L. Silvestri, and L. Pacifico, "Association of nonalcoholic fatty liver disease with subclinical cardiovascular changes: a systematic review and meta-analysis," BioMed Research International, vol. 2015, Article ID 213737, p. 11, 2015.
29. A. Mantovani, A. Rigamonti, S. Bonapace et al., "Nonalcoholic fatty liver disease is associated with ventricular arrhythmias in patients with type 2 diabetes referred for clinically indicated 24-hour Holter monitoring," Diabetes Care, vol. 39, no. 8, pp. 1416-1423, 2016.
30. P. Wainwright and C. D. Byrne, "Bidirectional relationships and disconnects between NAFLD and features of the metabolic syndrome," International Journal of Molecular Sciences, vol. 17, no. 3, 367 pages, 2016.
31. S. Francque, A. Verrijken, I. Mertens et al., "Visceral adiposity and insulin resistance are independent predictors of the presence of non-cirrhotic NAFLD-related portal hypertension," International Journal of Obesity, vol. 35, no. 2, pp. 270-278, 2011.
32. S. Krishan, "Correlation between non-alcoholic fatty liver disease (NAFLD) and dyslipidemia in type 2 diabetes," Diabetes and Metabolic Syndrome: Clinical Research and Reviews, vol. 10, 2 Supplement 1, pp. S77-S81, 2016.
33. D. R. Ewald and L. A. Haldeman, "Risk factors in adolescent hypertension," Global Pediatric Health, vol. 3, 2016.
34. M. Kanbay, T. Jensen, Y. Solak et al., "Uric acid in metabolic syndrome: from an innocent bystander to a central player," European Journal of Internal Medicine, vol. 29, pp. 3-8, 2016.
35. C. Xu, "Hyperuricemia and nonalcoholic fatty liver disease: from bedside to bench and back," Hepatology International, vol. 10, no. 2, pp. 286-293, 2016.
36. S. Gong, J. Song, L. Wang, S. Zhang, and Y. Wang, "Hyperuricemia and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis," European Journal of Gastroenterology & Hepatology, vol. 28, no. 2, pp. 132-138, 2016.
37. Y. Liu, C. Liu, X. Shi et al., "Correlations of nonalcoholic fatty liver disease and serum uric acid with subclinical atherosclerosis in obese Chinese adults," Journal of Diabetes, 2016.
38. J. Liu, C. Xu, L. Ying et al., "Relationship of serum uric acid level with non-alcoholic fatty liver disease and its inflammation progression in non-obese adults," Hepatology Research, 2016.
39. R. A. Sinha and P. M. Yen, "Thyroid hormone-mediated autophagy and mitochondrial turnover in NAFLD," Cell & Bioscience, vol. 6, no. 1, p. 46, 2016.
40. A. Bano, L. Chaker, E. P. Plompen et al., "Thyroid function and the risk of non-alcoholic fatty liver disease: the Rotterdam study," The Journal of Clinical Endocrinology and Metabolism, vol. 101, no. 8, pp. 3204-3211, 2016.